Partnership Opportunities

Why You Should Partner With Us

We are very serious about partnering, and are actively looking for partners. Bullet Bio is looking for partners to develop new capsid products targeting cancer, autoimmune diseases, or infectious diseases. For multi-specific antibody capsid products, we are interesting in talking with partners with monoclonal antibodies looking to enhance efficacy or improve the therapeutic index by combining with another antibody with a complementary effect. For therapeutic and prophylactic capsid vaccines, we are especially interested in partnering with companies who have proprietary:

  • Immune stimulants
  • Checkpoint inhibitors
  • Tumor-associated antigens

We can quickly conjugate development candidates to our customizable capsid and provide product for a feasibility study. The process development work we have accomplished with our BB products has given us expertise in making capsids and conjugating various proteins, antibodies, oligonucleotides, and small molecules, enabling us to efficiently deliver new capsid products.

Please contact us if you are interested in discussing a collaboration.